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Abstract 
Expression of dihydrofolate reductase (DHFR) and chloramphenicol acetyltransferase (CAT) mRNAs in cell-free Escherichia coli translation 
systems is greatly enhanced as a result of their insertion into RQ135 RNA, a naturally occurring satellite of phage Qj?. The enhancement is due to 
protection of the recombinant mRNAs against endogenous ribonucleases and to an increased initial rate of translation in the case of the RQ-CAT 
mRNA. 
Key words: QB phage; Satellite RQ RNA; Recombinant mRNA; Cell-free translation; mRNA stability 
1. Introduction 
RQ RNAs are small satellites of phage QB. They are 
formed by recombinations between RNAs occurring in 
the Qs phage-infected Escherichiu coli cells [l-3], are 
capable of amplification by Q@ replicase (RNA-directed 
RNA polymerase of phage Qj) [4], are incorporated into 
Q/I phage particles, and can propagate in a number of 
phage generations [5]. Initially, they were identified as 
‘6s RNAs’ in the infected E. coli cells [6] and as RNA 
species ‘spontaneously’ synthesized in vitro by purified 
Qj3 replicase, and were designated as Qj RNA ‘variants’ 
[7]. Recently, we have shown that the ‘spontaneous’ syn- 
thesis is caused by airborne RQ RNA molecules [4,8] and 
that RQ RNAs do not necessarily descend from the Q/3 
RNA sequence. In particular, RQ135(+) RNA, one of 
the most efficient Qj3 replicase templates, is mainly com- 
posed of sequences homologous to the 23 S ribosomal 
RNA [2]. 
In a previous study we have shown that RQ135 RNA 
can impart the ability of amplification by QJ3 replicase 
in vitro to DHFR mRNA inserted at one of its internal 
loops [9]. Replication of the RQ-DHFR mRNA recom- 
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binant proceeds efficiently if coupled to translation. Oth- 
erwise, replication is limited to one round resulting in a 
dead duplex formed by the annealed (+) and (-) strands. 
The translating ribosomes prevent duplex formation by 
sequestering the (+) strands and induce replication asym- 
metry that also characterizes the replication of QB RNA 
in vivo: the (+) strands are accumulated in large excess 
over the (-) strands, and this results in an increased 
synthesis of DHFR [9]. Thus, the behavior of the recom- 
binant RQ-DHFR mRNA in the cell-free replication- 
translation system mimics the replication of QB phage in 
vivo, although no part of RQ-DHFR mRNA has origi- 
nated from the phage genome. 
This paper reports other properties acquired by 
mRNAs inserted into the RQ135 sequence which 
strengthen the resemblance of the resulting recombinants 
to the phage genome, namely enhanced expression in E. 
coli cell-free translation systems and elevated resistance 
to the endogenous ribonucleases. 
2. Materials and methods 
RQ mRNA recombinants were constructed at the DNA level by 
inserting the corresponding enes into the XhoI site of mutant RQ135_, 
cDNA and prepared by runoff plasmid transcription with T7 RNA 
polymerase as described [9]. Plasmids pT7RQ135_,(-)DHFR(+) (cod- 
ing the recombinant RQ-DHFR mRNA) and pSP65DHFR,,, (used for 
synthesis of the control DHFR mRNA with SP6 RNA polymerase) 
were the same as in [9]. Plasmid pSPT19CAT (generously provided by 
Dr. Yarchuk of this Institute) was prepared by ligation, at site SalI 
plasmid pSPT19 (Pharmacia), of the CAT gene-carrying SalI cartridge 
excised from plasmid pCM-1 (Pharmacia). This plasmid was used for 
synthesis of the control CAT mRNA with T7 RNA polymerase (follow- 
ing digestion with EarnHI) and also as a source of the CAT gene for 
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construction of plasmid p~RQl35-,(-)CAT(+) coding for the recom- 
binant RQ-CAT mRNA. 
30 ~1 cell-free translation reactions [9] contained 25 pmol of the 
corresponding mRNA and either 1.75 A,, units of crude S30 extract 
[lo] (the ‘S30 system’) or 1.4 A,, units of 70 S ribosomes (obtained by 
mixing equimolar amounts of 30 S and 50 S ribosomal subpa~~cles [ 11 J) 
plus 12 fig of protein fraction SlOO 1121 (the ‘5100 system’). Protein 
synthesis was monitored by sampling 5 yl aliquots and either counting 
the radioactivity of [%]Met (170 Wmmol) in the trichloroacetic acid- 
precipitated material, or autoradiography of the electrophoretic pat- 
terns of the %labeled products 191. mRNA decay was monitored in 
the parallel translation reactions by analyzing the Toluidine blue- 
stained electrophoretic patterns of phenol/chloroform-extracted 6 ,ul 
aliquots [9]. 
3. Results 
The recombinant RQ-mRNAs used in this work con- 
tained E. coli DHFR and CAT mRNAs inserted between 
positions 53 and 54 of the (-) strand of RQ135_, RNA 
[2]. In addition to the 480 nt- and 657 nt-long sequences 
coding for DHFR and CAT, the inserts contained, re- 
spectively, the 15 nt- and 37 nt-long 5’ terminal, and the 
22 nt- and 93 nt-long 3’ terminal untranslated segments. 
The total lengths of the recombinant molecules were 650 
nt (RQ-DHFR mRNA) and 920 nt (RQ-CAT mRNA). 
The control mRNAs, DHFR mRNA (680 nt) and CAT 
mRNA (823 nt), contained the 36 nt- and 61 nt-long 5’ 
terminal, and the 165 nt- and 105 nt-long 3’ terminal 
untranslated regions, respectively. 
The expression of these mRNAs was studied in two 
cell-free translation systems, S30 and SlOO, prepared 
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from E. cob cells (see section 2). The S30 system con- 
tained crude E. coli extract and thus mimicked intracellu- 
lar conditions, whereas the SlOO system was deprived of 
most of the endogenous ribonucleases (mainly associated 
with ribosomes 1131) by washing the ribosomal subparti- 
cles with 0.5 M NH&l [ll]. 
In the S30 system, the expression of each of the RQ- 
mRNA recombinants was much more efficient than that 
of the respective control mRNAs (Fig. 1A). Parallel ex- 
amination of mRNA integrity showed that the enhanced 
expression of the recombinant mRNAs correlated with 
their approx. S-fold longer lifetimes (Fig. 1B). This sug- 
gests that the attachment of the RQ135 sequence to the 
mRNAs improves their expression by protecting them 
against ribonucleases occurring in the S30 extract. How- 
ever, the enhan~ment of expression was not propor- 
tional to the stabilization effect. Moreover, despite the 
equal stabilizing effects of the RQ13.5 moiety on DHFR 
and CAT mRNAs, the increase in protein synthesis (the 
plateau level) was 5-times greater in the case of CAT 
mRNA (15- to 20-fold; Fig. 1 A, right) than with DHFR 
mRNA (3- to 4-fold; Fig. lA, left). It follows that the 
observed increase in the expression level cannot be solely 
due to the mRNA protection. 
In order to discriminate between the protective action 
of the RQ135 moiety and the direct stimulation of 
mRNA translation, mRNA expression was studied in 
the SlOO system (Fig. 2). In this system the mRNAs 
degrade much slower than in the S30 system (cf. Figs. 2B 
and 1B) which allows the initial translation rates to be 
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Fig. 1. Expression of DHFR mRNA (I), RQ-DHFR mRNA (2), CAT mRNA (3) and RQ-CAT mRNA (4) in the S30 system. (A) Time-course 
of protein synthesis and electrophoretic pattern of the products synthesized up to 30 min (inset). (B) Timecourse of mRNA decay during translation. 
The corresponding mRNA transcripts were used as size markers (lanes R). The intense bands at the top of the gel correspond to ribosomal 23 S 
and 16 S RNAs. 
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Fig. 2. Expression of DHFR mRNA (I), RQ-DHFR mRNA (2), CAT mRNA (3) and RQ-CAT mRNA (4) in the SlOO system. (A) Time-course 
of protein synthesis and electrophoretic pattern of the products synthesized up to 90 min (inset). (B) Time-course of mRNA decay during translation. 
For other details see legend to Fig. 1. 
compared. The comparison shows that while the initial 
translation rates for the RQ-DHFR mRNA and the con- 
trol DHFR mRNA are indistinguishable, the RQ-CAT 
mRNA is translated at a .5-times higher initial rate than 
the control CAT mRNA (Fig. 2A). 
4. Discussion 
In a previous study we showed that the insertion of 
DHFR mRNA at an internal site of RQ135 RNA makes 
it amplifiable in a coupled, cell-free replication-transla- 
tion system and leads to a higher protein yield due to the 
synthesis of additional copies of the sense strands [9]. An 
increased protein production in a coupled replication- 
translation system over the non-coupled translation sys- 
tem has also been observed for CAT mRNA embedded 
within another RQ RNA, MDV-1 (RQ223) [14]. This 
work extends the earlier observations by showing that in 
addition to replicability, RQ RNA imparts to an mRNA 
insert a higher resistance to ribonucleases and can also 
increase the rate of its translation, possibly at the initia- 
tion step. The resulting gross enhancement of mRNA 
expression in a coupled replication-translation system is 
thus the sum of these three separate effects. 
The protective action of the RQ RNA moiety can 
readily be explained by the high resistance to ribonu- 
cleases of the RQ RNAs themselves. These RNAs pos- 
sess highly developed secondary structures and, presum- 
ably, stable molecule ‘stalks’ formed by the base-paired 
3’ and 5’ termini [ 1,2,15]. The latter feature can be impor- 
tant for RNA protection against 3’-exoribonucleases 
which are abundant in bacterial cells and play a major 
role in mRNA turnover in vivo [16]. There is ample 
evidence that mRNAs can be efficiently stabilized by 3’ 
terminal hairpin structures, both in vivo and in vitro 
[l&18]. The reason for the increase in the translation 
rate in not as apparent. RQ RNAs have been selected for 
their high replication rates and lack of any protein-cod- 
ing function 171, We can indicate two possibilities ex- 
plaining the stimulation by the RQ135 moiety of the 
translation of the CAT mRNA insert, (i) As RQ13.5 
RNA possesses a very stable tertiary structure {2] it 
should keep the 3’ and 5’ ends of the embedded mRNA 
together. This could induce a more favorable confor- 
mation of the mRNA moiety and promote translation, 
e.g. by exposing the ribosome-binding site. (ii) Another 
possibility could be accounted for by the fact that the (-) 
strand of RQ135 RNA, in which the mRNAs have been 
inserted, contains three long segments complementary to 
the 23 S ribosomal RNA [2] that could provide for addi- 
tional binding sites of the recombinant RQ-mRNAs on 
the ribosome. 
The replicability, elevated ribonuclease resistance, and 
high translation rates of the RQ-mRNA recomb~ants 
make them attractive templates for large-scale protein 
synthesis in vitro [19,20]. The high performance of such 
templates in a continuous-flow cell-free replication- 
translation system has recently been d~onstrated 
[14,21]. 
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